Interactions of Cortisol and Prolactin with Other Selected Menstrual Cycle Hormones Affecting the Chances of Conception in Infertile Women

One of the major problems of success in infertility treatment could depend on the understanding how the potential factors may affect the conception. The aim of this study was to evaluate present understanding of such factors or hormonal causes that may induce infertility. We studied the interactions between the two menstrual cycle hormones i.e., cortisol (COR) and prolactin (PRL), along with the ultrasonographic ovulation parameters in a group of N = 205 women with diagnosed infertility. The control group consisted of N = 100 women with confirmed fertility. In both groups, follicle-stimulating hormone (FSH), luteinizing hormone (LH), anti-Müllerian hormone (AMH), thyroid stimulating hormone (TSH), PRL, COR were examined on the third day of the cycle, and estradiol (E2), progesterone (P), and COR were examined during ovulation and 7-days afterwards. In the infertile group, higher levels of PRL and COR were observed than that of in the control group. Cortisol levels at all phases of the menstrual cycle and PRL negatively correlated with E2 secretion during and after ovulation, thus contributed to the attenuation of the ovulatory LH surge. Infertile women who conceived presented with higher levels of E2 during and after ovulation, higher P after ovulation, and thicker endometrium than that of the women who failed to conceive. In conclusion, elevated secretion of COR and PRL in infertile women impairs the menstrual cycle by decreasing the pre-ovulatory LH peak and E2 and postovulatory E2 levels that affect the endometrial growth, and consequently reduce the chances to conceive.

[1]  Yun-shan Zhang,et al.  Endometrial thickness and IVF cycle outcomes: a meta-analysis. , 2019, Reproductive biomedicine online.

[2]  J. Younis The role of progesterone/estradiol ratio in exploring the mechanism of late follicular progesterone elevation in low ovarian reserve women. , 2019, Medical hypotheses.

[3]  B. Seckin,et al.  The role of anti-Müllerian hormone in prediction of pregnancy in young and older women with unexplained infertility undergoing intrauterine insemination , 2019, Journal of the Chinese Medical Association : JCMA.

[4]  N. Polyzos,et al.  Low serum progesterone the day prior to frozen embryo transfer of euploid embryos is associated with significant reduction in live birth rates , 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[5]  J. García-Velasco,et al.  Very low anti-müllerian hormone concentrations are not an independent predictor of embryo quality and pregnancy rate. , 2018, Reproductive biomedicine online.

[6]  S. Cnattingius,et al.  A prospective investigation of perceived stress, infertility‐related stress, and cortisol levels in women undergoing in vitro fertilization: influence on embryo quality and clinical pregnancy rate , 2018, Acta obstetricia et gynecologica Scandinavica.

[7]  S. Trevisan,et al.  Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome , 2018, Human reproduction open.

[8]  D. Hodgson,et al.  Linking Stress and Infertility: A Novel Role for Ghrelin. , 2017, Endocrine reviews.

[9]  R. Kahn,et al.  Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis , 2017, Psychoneuroendocrinology.

[10]  M. Stec,et al.  Post-laparoscopy predictive factors of achieving pregnancy in patients treated for infertility , 2016, Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques.

[11]  S. K. Chaube,et al.  Impact of stress on oocyte quality and reproductive outcome , 2016, Journal of Biomedical Science.

[12]  A. Wdowiak,et al.  Ovarian stimulation with human and recombinant gonadotropin – comparison of in vitro fertilization efficiency with use of time-lapse monitoring , 2015, Reproductive Health.

[13]  Z. Rosenwaks,et al.  Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome. , 2014, Fertility and sterility.

[14]  E. Jouve,et al.  Prognosis factors of pregnancy after intrauterine insemination with the husband's sperm: conclusions of an analysis of 2,019 cycles. , 2014, Fertility and sterility.

[15]  M. Velez,et al.  Anti-Müllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF , 2014, Journal of Assisted Reproduction and Genetics.

[16]  D. Cahill,et al.  Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction , 2013, Obstetrics and gynecology international.

[17]  R. Stouffer,et al.  Endocrine and local control of the primate corpus luteum. , 2013, Reproductive biology.

[18]  E. Piccione,et al.  Can anti-Müllerian hormone be predictive of spontaneous onset of pregnancy in women with unexplained infertility? , 2013, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[19]  A. Stavreus-Evers,et al.  Predictive value of hormonal parameters for live birth in women with unexplained infertility and male infertility , 2013, Reproductive Biology and Endocrinology.

[20]  M. Meseguer,et al.  Dose of recombinant FSH and oestradiol concentration on day of HCG affect embryo development kinetics. , 2012, Reproductive biomedicine online.

[21]  B. Litschauer,et al.  Saliva cortisol levels and subjective stress are not associated with number of oocytes after controlled ovarian hyperstimulation in patients undergoing in vitro fertilization. , 2011, Fertility and sterility.

[22]  F. Tomei,et al.  Different ART outcomes at increasing peak estradiol levels with long and antagonist protocols: retrospective insights from ten years experience , 2011, Journal of Assisted Reproduction and Genetics.

[23]  G D Adamson,et al.  International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. , 2009, Fertility and sterility.

[24]  R. Stouffer Endocrine and Local Control of the Primate Corpus Luteum: 1973 to Today.Richard L. Stouffer, Ph.D. , 2009 .

[25]  A. Papageorghiou,et al.  Potential significance of physiological and pharmacological glucocorticoids in early pregnancy. , 2008, Human reproduction update.

[26]  P. Devroey,et al.  The role of the endometrium and embryo in human implantation. , 2007, Human reproduction update.

[27]  S. Patel,et al.  Hyperprolactinaemia , 2007, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[28]  B. Strassmann,et al.  Cortisol levels and very early pregnancy loss in humans. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Kitamura,et al.  Activation of estrogen response element dependent transcription by thyroid hormone with increase in estrogen receptor levels in a rat pituitary cell line, GH3. , 2004, The Journal of endocrinology.

[30]  A. Durlinger,et al.  Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. , 2002, Endocrinology.

[31]  N. Josso,et al.  Anti-Müllerian hormone and its receptors , 2001, Molecular and Cellular Endocrinology.

[32]  C. Simón,et al.  Paracrine regulators of implantation. , 2000, Bailliere's best practice & research. Clinical obstetrics & gynaecology.

[33]  B. Landgren,et al.  The influence of stress and state anxiety on the outcome of IVF‐treatment: Psychological and endocrinological assessment of Swedish women entering IVF‐treatment , 2000, Acta obstetricia et gynecologica Scandinavica.

[34]  H. Matsuo,et al.  The role of thyroid hormone as a biological amplifier of the actions of follicle-stimulating hormone in the functional differentiation of cultured porcine granulosa cells. , 1987, Endocrinology.

[35]  J. Butler,et al.  Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. , 1984, The Journal of clinical investigation.

[36]  S. Wolczynski,et al.  Diagnostyka i leczenie niepłodności – rekomendacje Polskiego Towarzystwa Medycyny Rozrodu i Embriologii (PTMRiE) oraz Polskiego Towarzystwa Ginekologów i Położników (PTGP) , 2018 .

[37]  S. Adiga,et al.  Is there a Need for Luteinizing Hormone (LH) Estimation in Patients Undergoing Ovarian Stimulation with Gonadotropin-Releasing Hormone (GnRH) Antagonists and Recombinant Follicle-Stimulating Hormone (rFSH)? , 2014, Journal of clinical and diagnostic research : JCDR.

[38]  Yuan An,et al.  Relationship between psychological stress and reproductive outcome in women undergoing in vitro fertilization treatment: Psychological and neurohormonal assessment , 2012, Journal of Assisted Reproduction and Genetics.

[39]  Elizabeth Noonan,et al.  World Health Organization reference values for human semen characteristics. , 2010, Human reproduction update.

[40]  V. Toscano,et al.  Dynamic evaluation of ovarian reserve and abnormal androgen excess in women. , 2003, Journal of endocrinological investigation.